Has The Era Of Slow Growth For Prescription Drug Spending Ended?
In the period 2005–13 the US prescription drug market grew at an average annual pace of only 1.8 percent in real terms on an invoice price basis (that is, in constant dollars and before manufacturers’ rebates and discounts). But the growth rate increased dramatically in 2014, when the market expande...
Main Authors: | Aitken, M., Cutler, D., Kleinrock, M., Maini, L., Berndt, Ernst R |
---|---|
Other Authors: | Sloan School of Management |
Format: | Article |
Language: | en_US |
Published: |
Project Hope
2017
|
Online Access: | http://hdl.handle.net/1721.1/108623 https://orcid.org/0000-0002-6388-0768 |
Similar Items
-
Promotion of Prescription Drugs to Consumers and Providers, 2001–2010
by: Kornfield, Rachel, et al.
Published: (2013) -
China’s Defence Spending: Settling in for Slow Growth?
by: Bitzinger, Richard A.
Published: (2017) -
The origin of compulsory drug prescriptions
by: Temin, Peter
Published: (2011) -
Navy design spending in an era of acquisition reform
by: Grimsley, Jennifer S. (Jennifer Suzanne), 1976-
Published: (2013) -
Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
by: Trusheim, Mark, et al.
Published: (2011)